Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment

Background: Intravesical injection of Botulinum toxin A (BoNT-A) and platelet-rich plasma (PRP) have been reported to alleviate bladder pain and decrease nocturia in patients with refractory interstitial cystitis/bladder pain syndrome (IC/BPS). Both treatments are novel and there has no comparison b...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhang, Jia-Fong, Yu, Wan-Ru, Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961286/
https://www.ncbi.nlm.nih.gov/pubmed/36828435
http://dx.doi.org/10.3390/toxins15020121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961286/
https://www.ncbi.nlm.nih.gov/pubmed/36828435
http://dx.doi.org/10.3390/toxins15020121

Ejemplares similares